MDNA:CC News and Press, Medicenna Therapeutics Corp.

News Releases

MDNA:CC News Releases

September 03, 2026 07:00:00 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference

June 26, 2026 08:51:12 am

MDNA:CC : TSXC

SeekingAlpha

Medicenna Therapeutics Corp. GAAP EPS of -C$0.22

June 26, 2026 08:45:57 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights

June 24, 2026 07:00:18 am

MDNA:CC : TSXC

Canadian Earnings Reports

Expected Canadian Company Earnings on Wednesday, June 24th, 2026

June 11, 2026 07:00:00 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

June 03, 2026 07:00:00 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

May 28, 2026 09:10:38 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs

May 22, 2026 07:00:00 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet

May 19, 2026 07:00:00 am

MDNA:CC : TSXC

GlobeNewswire

Medicenna Announces the Finalization of the Terms of its Public Offering of Securities

May 13, 2026 04:08:49 pm

MDNA:CC : TSXC

SeekingAlpha

Medicenna launches marketed public offering of securities

	Next 10

Medicenna Therapeutics Corp. (TSXC : MDNA:CC ) News

News Releases

Subscribe to Our Newsletter

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Link Market Wire News to Your X Account